5/4/2025

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Colchicina Seid

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Kolkicin

Kolkicin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Teva. Colrefuz Produktresumé. Läkemedelsverket [www]. [updated 2023-02-20, cited 2025-01-29].

  2. Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387.

  3. Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):115-8.

  4. Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916-919.

  5. Iskender D, Kara O, Ozturk Kaymak A, Daglar HK, Kirbas A, Iskender CT et al. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever. J Obstet Gynaecol. 2020;40(8):1102-1105.

  6. Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol. 2010;203(2):144e1-6.

  7. Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving Colchicine: Is amniocentesis justified?. Arthrtis Care and Research 2010;62; 143-148. 2010.

  8. Rabinovitch O.Zemer D. Kukia E. Sohar E. Mashiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245-6.

  9. Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 2005;193:1513-6.

  10. UK Teratology Information Service (UKTIS). Use of colchicine in pregnancy September 2021 Verion 1. UKTIS [www]. [cited 2024-10-23].

  11. Singer A, Grinshpun-Cohen J, Sagi-Dain L. Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review. Rheumatology (Oxford). 2021;60(5):2342-2347.

  1. Teva. Colrefuz Produktresumé. Läkemedelsverket [www]. [updated 2023-02-20, cited 2025-01-29].
  2. Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387.
  3. Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):115-8.
  4. Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916-919.
  5. Iskender D, Kara O, Ozturk Kaymak A, Daglar HK, Kirbas A, Iskender CT et al. Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever. J Obstet Gynaecol. 2020;40(8):1102-1105.
  6. Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol. 2010;203(2):144e1-6.
  7. Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving Colchicine: Is amniocentesis justified?. Arthrtis Care and Research 2010;62; 143-148. 2010.
  8. Rabinovitch O.Zemer D. Kukia E. Sohar E. Mashiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245-6.
  9. Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 2005;193:1513-6.
  10. UK Teratology Information Service (UKTIS). Use of colchicine in pregnancy September 2021 Verion 1. UKTIS [www]. [cited 2024-10-23].
  11. Singer A, Grinshpun-Cohen J, Sagi-Dain L. Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review. Rheumatology (Oxford). 2021;60(5):2342-2347.